9. Results and key figures

The past year was another intense and successful year for Gimv. We invested in 11 promising new companies and at the same time, market conditions remained favourable, permitting 12 exits with a positive impact on income. Our active investment approach, together with the significant value creation in our portfolio, enabled us to post a strong result for the 2016-2017 financial year. The 19% portfolio yield translates into a net profit of EUR 131.9 million.

Top

Strong year result of EUR 131.9 million

For FY 2016-2017 Gimv posted a net profit (group share) of EUR 131.9 million, compared with a net profit of EUR 137.2 million in FY 2015-2016. More than half of this result consists of the realised capital gains on the divestments of the past year, and the balance of the unrealised capital gains on the portfolio.

Net realised capitalgains during FY 2016-2017 amounted to EUR 84.3 million (2015-2016: EUR 70.5 million). 88% of these net capital gains were realised in the four investment platforms, with all platforms making a positive contribution. Smart Industries contributed EUR 51.2 million, followed by Connected Consumer with EUR 11.4 million, Health & Care with EUR 6.3 million and Sustainable Cities with EUR 5.4 million. Finally, EUR 9.9 million of capital gains were realised on the distributions from third-party funds and the sale of the shareholding in the listed Capman entity.

Net unrealised capitalgains totalled EUR 55.7 million (vs. EUR 88.7 million in FY 2015-2016), coming mainly from Sustainable Cities (EUR 22.9 million) and Connected Consumer (EUR 21.8 million). But Smart Industries (EUR 14.1 million) and Health & Care (EUR 7.4 million) also made positive contributions. The third-party funds and other shareholdings, on the other hand, delivered a negative contribution (EUR -10.5 million). 

Top

The net unrealised capital gains are a direct consequence of the application of the prevailing international private equity valuation rules. On the one hand, these net unrealised capital gains are due primarily to a number of positive elements: (i) a decrease in net financial debt in the shareholdings (EUR 20.8 million), (ii) the increased share price of a number of listed shareholdings (EUR 16.6 million), (iii) the better results at the majority of shareholdings (EUR 15.2 million), (iv) the first revaluation of a number of shareholdings (EUR 12.7 million), (v) the upcoming sale of the shareholding in Teads (EUR 4.5 million), (vi) increased multiples (EUR 3.1 million), and (vii) positive exchange rate effects (EUR 0.1 million). On the other hand, there were also a number of negative elements: (viii) an impairment loss (EUR -9.2 million), (ix) a decrease in the value of the third-party funds (EUR -3.1 million) and (x) a number of minor value adjustments 1 (combined effect of EUR -5.1 million).

The other operating result for FY 2016-2017 2 came out at EUR 11.5 million, compared with EUR -8.5 million in FY 2015-2016. On the one side, the other operating income increased by three-quarters (EUR 59.2 million vs. EUR 33.5 million), mainly due to an increase in dividends received (EUR +27.2 million). On the other side, other operating expenses (including transaction costs) increased only slightly (EUR 47.7 million versus 42.0 million).

The net financial result fr the year is EUR 1.7 million positive, in line with 2015-2016 (EUR 1.8 million).

After deducting taxes (EUR -3.5 million) and non-controlling interests (EUR -17.8 million), Gimv realised for the 2016-2017 financial year a net profit (group share) of EUR 131.9 million.

1. This reduction in value is primarily due to the payment of a dividend by Gimv-XL Partners.
2. Dividends, interest, management fees, turnover and other operating income, after deducting services and other goods, personnel costs, amortization of intangible fixed assets, depreciation of land, buildings and equipment, and other operating costs.

Top

Active investment year

In FY 2016-2017, Gimv made in all EUR 179.6 million of on-balance sheet investments (EUR 130.2 million in FY 2015-2106). An additional EUR 16.2 million were also invested via the co-investment funds (as minority interests), bringing the total investments (on balance sheet and via the co-investment funds) to EUR 195.8 million(EUR 162.5 million in FY 2015-2016). The past financial year saw significant investments in the various investment platforms. The Smart Industries portfolio expanded with investments in ALT Technologies, Arplas, MEGA International and Summa. In addition, first-time investments were made in Acceo (Sustainable Cities), Breath Therapeutics, EndoStim, G-Therapeutics and Spineart (Health & Care), and Joolz and Real Impact Analytics (Connected Consumer). There were also follow-on investments in, among others, Biom’Up, Brakel, Ecochem, Europlasma, Itineris, Jenavalve, OTN, TINC and Topas Therapeutics. 

Top

Record divestments

In 2016-2017, Gimv sold its shares, among others, in Altaïr/Brunel, Biodiesel Holding (Bioro), BMC, GreenPeak, Hecht, Lampiris, Leyton, Multiplicom, Nomadesk, Onedirect, Punch Powertrain and Vandemoortele. Added to these were a large number of distributions from the third-party funds. For these divestments Gimv received in all EUR 394.3 million (227.2 million in 2015-2016). Additional divestments via the co-investment funds (minority interests) added a further EUR 313.5 million(EUR 76.3 million in 2015-2016), bringing total divestments (on balance sheet and via co-investment funds) to EUR 707.8 million (EUR 303.5 million in 2015-2016).

On top of the sales proceeds of EUR 394.3 million, the sold shareholdings generated during FY 2016-2017 EUR 1.7 million of dividends, interest and management fees. In this way, sold shareholdings produced a total of EUR 396.0 million. On 31 March 2016 these divestments were carried at a total value of EUR 312.1 million. Consequently, the sales generated 26.9% more (EUR 83.9 million) than their carrying value at 31 March 2016 (measured at fair value in the consolidated figures). Over the entire period the realised money multiple on these sold shareholdings was 2.3x (i.e. versus their investment cost).

Top

Portfolio represents three quarters of total assets

Total assets amounted at 31 March 2017 to EUR 1 315.3 million. The portfolio amounts to EUR 963.6 million compared with EUR 1 013.9 million at 31 March 2016. The decrease in the total portfolio is relatively limited, especially taking into account the important level of divestments. This is explained by the EUR 179.6 million of new investments, in addition to the rise in value of the existing shareholdings in the portfolio.

Top

Net cash position amounts to a quarter of total assets

Gimv's net cash position at the end of March 2017 is EUR 313.9 million, compared with EUR 183.9 million 3 at 31 March 2016. This increase is explained by the significant divestments in the first half of the year.

3. Cash and cash equivalents of EUR 192.8 million, corrected for advance payments to be paid from divestments

Equity rises further to EUR 1 233.2 million or EUR 48.50 per share

Equity (group's share) (= net asset value) amounted at 31 March 2017 to EUR 1 233.2 million(EUR 48.50 per share), as against EUR 1 167.9 million(EUR 45.93 per share) at 31 March 2016.  The increase in equity during FY 2016-2017, combined with the dividends of EUR 62.3 million paid out during the financial year, represents an economic return on equity for the financial year of 11.0%, in line with Gimv’s long-term return.

Top

Research and development

Gimv and its consolidated subsidiaries did not undertake any research and development activities during the past year.

Top

Key figures

31-03-201731-03-201631-03-201531-03-201431-03-2013
Consolidated financial statements (in EUR 000)
Equity 1 233 1771 167 8871 092 636992 0431 011 829
Portfolio 963 5851 013 894 920 189930 959814 357
Cash and cash equivalents 313 906 192 774 184 76656 637195 297
Net cash and cash equivalents 313 906 183 881 184 76656 637195 297
Balance sheet total1 315 2601 230 3291 136 0481 026 7211 072 483
Net profit 131 853 137 175 135 99114 99832 746
Total gross dividend (1)63 56762 29562 29560 57658 711
Investments (own balance sheet) 179 628 130 220 154 283194 566110 806
Investments (including co-investment partnerships) 195 795 162 492 190 958264 768150 888
Divestments (own balance sheet) 394 346 227 168 331 96095 765180 686
Divestments (including co-investment partnerships) 707 817 303 468 367 431131 143254 833
Number of employees 93 95 1039997
Key figures per share (in EUR)
Equity 48.5045.9342.9740.1242.22
Net profit 5.195.395.350.611.37
Diluted net profit 5.195.395.350.611.37
Gross dividend (1)2.502.452.452.452.45
Share price (on the closing date of the financial year)52.3148.5041.8937.1238.99
Total number of shares 25 426 67225 426 67225 426 67224 724 78023 963 786
Ratios
Pay-out ratio 48.2%45.4%45.8%403.9%179.3%
Net return on equity 11.0%12.6%13.7%1.5%3.2%
Gross return on portfolio (2)18.8%20.0%17.3%3.8%5.9%
Premium (+) / discount (-) on equity 7.9%5.6%-2.6%-7.5%-7.7%
31-03-201731-03-201631-03-201531-03-201431-03-2013
Consolidated financial statements (in EUR 000)
Equity 1 233 1771 167 8871 092 636992 0431 011 829
Portfolio 963 5851 013 894 920 189930 959814 357
Cash and cash equivalents 313 906 192 774 184 76656 637195 297
Net cash and cash equivalents 313 906 183 881 184 76656 637195 297
Balance sheet total1 315 2601 230 3291 136 0481 026 7211 072 483
Net profit 131 853 137 175 135 99114 99832 746
Total gross dividend (1)63 56762 29562 29560 57658 711
Investments (own balance sheet) 179 628 130 220 154 283194 566110 806
Investments (including co-investment partnerships) 195 795 162 492 190 958264 768150 888
Divestments (own balance sheet) 394 346 227 168 331 96095 765180 686
Divestments (including co-investment partnerships) 707 817 303 468 367 431131 143254 833
Number of employees 93 95 1039997
Key figures per share (in EUR)
Equity 48.5045.9342.9740.1242.22
Net profit 5.195.395.350.611.37
Diluted net profit 5.195.395.350.611.37
Gross dividend (1)2.502.452.452.452.45
Share price (on the closing date of the financial year)52.3148.5041.8937.1238.99
Total number of shares 25 426 67225 426 67225 426 67224 724 78023 963 786
Ratios
Pay-out ratio 48.2%45.4%45.8%403.9%179.3%
Net return on equity 11.0%12.6%13.7%1.5%3.2%
Gross return on portfolio (2)18.8%20.0%17.3%3.8%5.9%
Premium (+) / discount (-) on equity 7.9%5.6%-2.6%-7.5%-7.7%
1. For the financial years 2012-2013 and 2013-2014 paid out as an optional dividend
2. (Realised capital gains + unrealised capital gains on financial fixed assets + dividends + interests + management fees + turnover) / portfolio at start of financial year

Top